MedPath

Endogastric Solutions

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:4

Trial Phases

1 Phases

Not Applicable:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
7 (100.0%)

Hernia Reduction Prior to Scheduled TIF Completion

Not Applicable
Terminated
Conditions
Fundoplication
First Posted Date
2017-09-12
Last Posted Date
2021-02-10
Lead Sponsor
EndoGastric Solutions
Target Recruit Count
14
Registration Number
NCT03280121
Locations
πŸ‡ΊπŸ‡Έ

Elkhart General Hospital, Elkhart, Indiana, United States

πŸ‡ΊπŸ‡Έ

Aspirus Iron River Hospital, Iron River, Michigan, United States

πŸ‡ΊπŸ‡Έ

Northern Nevada Medical Center, Sparks, Nevada, United States

The EndoGastric Solutions TEMPO Trial

Not Applicable
Completed
Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
Drug: PPI
Device: EsophyX System with SerosaFuse fasteners
First Posted Date
2012-07-24
Last Posted Date
2020-11-23
Lead Sponsor
EndoGastric Solutions
Target Recruit Count
65
Registration Number
NCT01647958
Locations
πŸ‡ΊπŸ‡Έ

EndoGastric Solutions, Redmond, Washington, United States

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

Not Applicable
Terminated
Conditions
Gastroesophageal Reflux Disease (GERD)
First Posted Date
2011-04-04
Last Posted Date
2020-12-03
Lead Sponsor
EndoGastric Solutions
Target Recruit Count
110
Registration Number
NCT01327963
Locations
πŸ‡ΊπŸ‡Έ

Munroe Regional Medical Center, Ocala, Florida, United States

πŸ‡ΊπŸ‡Έ

Livingston Hospital and Healthcare Services, Inc. CAH, Salem, Kentucky, United States

Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

Not Applicable
Completed
Conditions
Hiatal Hernia
Gastroesophageal Reflux Disease
First Posted Date
2010-06-04
Last Posted Date
2021-12-03
Lead Sponsor
EndoGastric Solutions
Target Recruit Count
129
Registration Number
NCT01136980
Locations
πŸ‡ΊπŸ‡Έ

Cedars Sinai Medical Center, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

SurgOne PC, Englewood, Colorado, United States

πŸ‡ΊπŸ‡Έ

Northwestern University, Chicago, Illinois, United States

and more 6 locations

Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)

Not Applicable
Completed
Conditions
Hiatal Hernia
Gastroesophageal Reflux Disease
First Posted Date
2010-05-06
Last Posted Date
2019-03-06
Lead Sponsor
EndoGastric Solutions
Target Recruit Count
278
Registration Number
NCT01118585
Locations
πŸ‡ΊπŸ‡Έ

Mt. Graham Regional Medical Center, Safford, Arizona, United States

πŸ‡ΊπŸ‡Έ

Tempe St. Luke's Hospital, Tempe, Arizona, United States

πŸ‡ΊπŸ‡Έ

Swedish Medical Center and SurgOne P.C., Englewood, Colorado, United States

and more 11 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.